Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Language
Year range
1.
Rev. Assoc. Med. Bras. (1992) ; 63(5): 435-440, May 2017. tab, graf
Article in English | LILACS | ID: biblio-896349

ABSTRACT

Summary Objective: The aim of this study was to evaluate the effect of rhubarb on extravascular lung water (EVLW) in patients with acute respiratory distress syndrome (ARDS). Method: A total of 80 patients with ARDS were randomly divided into a treatment group (40 cases) and control group (40 cases). Patients in the treatment group received rhubarb (30.0 g/d) and patients in the control group received conventional therapy for seven consecutive days. Extravascular lung water index (EVLWI) and pulmonary vascular permeability index (PVPI) were determined using pulse contour cardiac output (PiCCO) technology, and the oxygenation index was measured by blood gas analysis at baseline and on days 3, 5 and 7 after treatment. Results: The oxygenation index was higher and the levels of EVLWI and PVPI were lower after treatment in the two groups; however, these indexes showed significant differences on the 5th and 7th days after rhubarb treatment compared with the results in the control group (p<0.05). Conclusion: Rhubarb can decrease EVLWI and PVPI, and improve oxygenation in patients with ARDS.


Subject(s)
Humans , Male , Female , Adult , Aged , Young Adult , Respiratory Distress Syndrome/drug therapy , Rheum/chemistry , Drugs, Chinese Herbal/therapeutic use , Extravascular Lung Water/drug effects , Oxygen/physiology , Pulmonary Edema/drug therapy , Respiratory Distress Syndrome/physiopathology , Time Factors , Blood Gas Analysis , Capillary Permeability/drug effects , Capillary Permeability/physiology , Cardiac Output/drug effects , Cardiac Output/physiology , Extravascular Lung Water/physiology , Reproducibility of Results , Analysis of Variance , Treatment Outcome , Lung/drug effects , Lung/physiopathology , Middle Aged
2.
J Biosci ; 2012 Jun; 37 (2): 243-257
Article in English | IMSEAR | ID: sea-161668

ABSTRACT

Of all the causes identified for the disease hyper-immunoglobulinemia E syndrome (HIES), a homozygous mutation in tyrosine kinase2 (TYK2) and heterozygous mutations in STAT3 are implicated the defects in Jak/STAT signalling pathway in the pathogenesis of HIES. Mutations of STAT3 have been frequently clinically identified in autosomaldominant (AD) HIES patients’ cells, and therefore, the genotype of STAT3 has been associated with the phenotype of HIES. Here, we conducted studies on the functional loss of the seven specific STAT3 mutations correlated with ADHIES. Using STAT3-null human colon carcinoma cell line A4 cells, we generated seven mutants of STAT3 bearing single mutations clinically identified in AD-HIES patients’ cells and studied the functional loss of these mutants in IL- 6-Jak/STAT3 signalling pathway. Our results show that five STAT3 mutants bearing mutations in the DNA-binding domain maintain the phosphorylation of Tyr705 and the ability of dimerization while the other two with mutations in SH2 domain are devoid of the phosphorylation of Try705 and abrogate the dimerization in response to IL-6. The phosphorylation of Ser727 in these mutants shows diversity in response to IL-6. These mutations eventually converge on the abnormalities of the IL-6/Gp130/Jak2-mediated STAT3 transactivation on target genes, indicative of the dysregulation of JAK/STAT signalling present in HIES.

SELECTION OF CITATIONS
SEARCH DETAIL